Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of non-small cell lung cancer (NSCLC), either used in monotherapy or in combination with chemotherapy. While some patients achieve durable responses, some will not get benefit from this treatment. Early identification of...

Full description

Bibliographic Details
Main Authors: Yolanda Lage Alfranca, María Eugenia Olmedo Garcia, Ana Gómez Rueda, Pablo Álvarez Ballesteros, Diana Rosero Rodríguez, Marisa Torres Velasco
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Clinical Medicine
Subjects:
non-small cell lung cancer
immunotherapy
blood biomarker
Online Access:https://www.mdpi.com/2077-0383/11/11/3245

Internet

https://www.mdpi.com/2077-0383/11/11/3245

Similar Items